Peptide-drug conjugates (PDCs) represent a cutting-edge frontier in oncology therapeutics, combining the specificity of peptides with the potent cell-killing power of cytotoxic agents.
Peptide-drug conjugates (PDCs) represent a cutting-edge frontier in oncology therapeutics, combining the specificity of peptides with the potent cell-killing power of cytotoxic agents.